K-numberK243780
Device nameHELIOS 785 Pico (1754V2)
ApplicantLaseroptek Co., Ltd.
Product codeGEX
Device classClass II
Decision dateFeb 7, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The HELIOS 785 Pico is a Q-switched Nd:YAG laser system combined with a gain-switched Ti:Sapphire laser for surgical and dermatological use. It operates at three wavelengths (1064 nm, 532 nm, and 785 nm) to perform procedures including tattoo removal, hair removal, treatment of pigmented and vascular lesions, skin resurfacing, and soft tissue ablation across Fitzpatrick skin types I–VI.

Technological characteristics

The proposed device matches the primary predicate (K230373) in wavelengths, pulse durations, pulse energies, spot sizes, repetition rates, laser types, activation method, display, electrical power, beam delivery system, and physical dimensions. The proposed device adds new operating modes (RTP and FR modes at 1064 nm) with increased pulse energy (2.0 J and 3.0 J respectively) and expanded indications including treatment of melasma, acne scars, wrinkles, and pseudofolliculitis barbae.

Test standards cited

Basic safety and essential performance per IEC 60601-1; electromagnetic compatibility per IEC 60601-1-2; laser safety per IEC 60825-1:2014; risk management per ISO 14971; usability per IEC 60601-1-6; and particular requirements for surgical and cosmetic laser equipment per IEC 60601-2-22.

Substantial equivalence argument

The device uses substantially identical laser technology, optical design, and beam delivery as the predicate K230373 with matching core specifications. Although it introduces new operating modes and expanded indications, these enhancements do not alter the fundamental principles of operation or introduce new safety concerns, as they use the same wavelengths and similar pulse characteristics already established in the predicate's substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →